Identification of HLA-unrestricted CD8+/CD28- cytotoxic T-cell clones specific for leukemic blasts in children with acute leukemia

D. Montagna, M. Arico, E. Montini, F. De Benedetti, R. Maccario

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

We report on the identification of 57 T-cell clones (TCC) cytolytic to autologous leukemic blasts (LB) but not autologous bone marrow remission cells. LB-reactive TCC were obtained from 3 children with acute leukemia at remission; all expressed the same phenotype, CD3/TCRαβ/CD8+, but were heterogeneous for the expression of Vβ T-cell receptor (TCR) V region chains, thus showing that these cells were not derived from the expansion of a single clone. Cytolytic activity of LB-reactive TCC was not restricted to autologous LB because they were also able to lyse phenotypically similar allogeneic LB but not bone marrow remission cells of the same patients. Neither autologous nor allogeneic LB used in the present study as stimulator and target cells expressed CD80 (B7/BB-1) antigen, and LB-reactive TCC were CD28-. Cytolytic activity of the clones was only inhibited by anti-CD11a (LFA-1) mAb but not by mAbs specific for HLA class I and II, CD3, CD8, or TCRαβ. In conclusion, these data suggest that a subset of apparently HLA- unrestricted, CD3/TCRαβ/CD8+ CD28- cytotoxic T lymphocytes, which use a TCR/CD3-independent recognition pathway, is primarily involved in antitumor immune response of children with acute leukemia at remission, possibly contributing to the control of minimal residual disease.

Original languageEnglish
Pages (from-to)3835-3839
Number of pages5
JournalCancer Research
Volume55
Issue number17
Publication statusPublished - 1995

Fingerprint

T-Cell Antigen Receptor
Leukemia
Clone Cells
T-Lymphocytes
Bone Marrow Cells
CD80 Antigens
Lymphocyte Function-Associated Antigen-1
Residual Neoplasm
Cytotoxic T-Lymphocytes
Phenotype

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Identification of HLA-unrestricted CD8+/CD28- cytotoxic T-cell clones specific for leukemic blasts in children with acute leukemia. / Montagna, D.; Arico, M.; Montini, E.; De Benedetti, F.; Maccario, R.

In: Cancer Research, Vol. 55, No. 17, 1995, p. 3835-3839.

Research output: Contribution to journalArticle

@article{21d7fc0f1d76454db6221745d18ea492,
title = "Identification of HLA-unrestricted CD8+/CD28- cytotoxic T-cell clones specific for leukemic blasts in children with acute leukemia",
abstract = "We report on the identification of 57 T-cell clones (TCC) cytolytic to autologous leukemic blasts (LB) but not autologous bone marrow remission cells. LB-reactive TCC were obtained from 3 children with acute leukemia at remission; all expressed the same phenotype, CD3/TCRαβ/CD8+, but were heterogeneous for the expression of Vβ T-cell receptor (TCR) V region chains, thus showing that these cells were not derived from the expansion of a single clone. Cytolytic activity of LB-reactive TCC was not restricted to autologous LB because they were also able to lyse phenotypically similar allogeneic LB but not bone marrow remission cells of the same patients. Neither autologous nor allogeneic LB used in the present study as stimulator and target cells expressed CD80 (B7/BB-1) antigen, and LB-reactive TCC were CD28-. Cytolytic activity of the clones was only inhibited by anti-CD11a (LFA-1) mAb but not by mAbs specific for HLA class I and II, CD3, CD8, or TCRαβ. In conclusion, these data suggest that a subset of apparently HLA- unrestricted, CD3/TCRαβ/CD8+ CD28- cytotoxic T lymphocytes, which use a TCR/CD3-independent recognition pathway, is primarily involved in antitumor immune response of children with acute leukemia at remission, possibly contributing to the control of minimal residual disease.",
author = "D. Montagna and M. Arico and E. Montini and {De Benedetti}, F. and R. Maccario",
year = "1995",
language = "English",
volume = "55",
pages = "3835--3839",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "17",

}

TY - JOUR

T1 - Identification of HLA-unrestricted CD8+/CD28- cytotoxic T-cell clones specific for leukemic blasts in children with acute leukemia

AU - Montagna, D.

AU - Arico, M.

AU - Montini, E.

AU - De Benedetti, F.

AU - Maccario, R.

PY - 1995

Y1 - 1995

N2 - We report on the identification of 57 T-cell clones (TCC) cytolytic to autologous leukemic blasts (LB) but not autologous bone marrow remission cells. LB-reactive TCC were obtained from 3 children with acute leukemia at remission; all expressed the same phenotype, CD3/TCRαβ/CD8+, but were heterogeneous for the expression of Vβ T-cell receptor (TCR) V region chains, thus showing that these cells were not derived from the expansion of a single clone. Cytolytic activity of LB-reactive TCC was not restricted to autologous LB because they were also able to lyse phenotypically similar allogeneic LB but not bone marrow remission cells of the same patients. Neither autologous nor allogeneic LB used in the present study as stimulator and target cells expressed CD80 (B7/BB-1) antigen, and LB-reactive TCC were CD28-. Cytolytic activity of the clones was only inhibited by anti-CD11a (LFA-1) mAb but not by mAbs specific for HLA class I and II, CD3, CD8, or TCRαβ. In conclusion, these data suggest that a subset of apparently HLA- unrestricted, CD3/TCRαβ/CD8+ CD28- cytotoxic T lymphocytes, which use a TCR/CD3-independent recognition pathway, is primarily involved in antitumor immune response of children with acute leukemia at remission, possibly contributing to the control of minimal residual disease.

AB - We report on the identification of 57 T-cell clones (TCC) cytolytic to autologous leukemic blasts (LB) but not autologous bone marrow remission cells. LB-reactive TCC were obtained from 3 children with acute leukemia at remission; all expressed the same phenotype, CD3/TCRαβ/CD8+, but were heterogeneous for the expression of Vβ T-cell receptor (TCR) V region chains, thus showing that these cells were not derived from the expansion of a single clone. Cytolytic activity of LB-reactive TCC was not restricted to autologous LB because they were also able to lyse phenotypically similar allogeneic LB but not bone marrow remission cells of the same patients. Neither autologous nor allogeneic LB used in the present study as stimulator and target cells expressed CD80 (B7/BB-1) antigen, and LB-reactive TCC were CD28-. Cytolytic activity of the clones was only inhibited by anti-CD11a (LFA-1) mAb but not by mAbs specific for HLA class I and II, CD3, CD8, or TCRαβ. In conclusion, these data suggest that a subset of apparently HLA- unrestricted, CD3/TCRαβ/CD8+ CD28- cytotoxic T lymphocytes, which use a TCR/CD3-independent recognition pathway, is primarily involved in antitumor immune response of children with acute leukemia at remission, possibly contributing to the control of minimal residual disease.

UR - http://www.scopus.com/inward/record.url?scp=0029150247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029150247&partnerID=8YFLogxK

M3 - Article

C2 - 7641201

AN - SCOPUS:0029150247

VL - 55

SP - 3835

EP - 3839

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 17

ER -